Viewing Study NCT01712100


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-02-17 @ 8:44 PM
Study NCT ID: NCT01712100
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
Sponsor: Roxane Laboratories
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module